AbbVie to present HCV data in November

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

AbbVie (ABBV +1.9%) will present new HCV data at AASLD in November.

Investors will get a look at SVR12 data from PEARL-1 and additional analyses from AVIATOR. (PR)

Worth remembering: ABT-450 was discovered in collaboration with Enanta (ENTA -0.1%).